Oxford Neuroscience

Oxford Neuroscience
Name	Oxford Neuroscience
Location	Oxford, United Kingdom
Established	2006
Type	Research and teaching network
Affiliation	University of Oxford
Director	Nigel Sherriff

Oxford Neuroscience Oxford Neuroscience is an interdisciplinary network within the University of Oxford that coordinates research, teaching, and clinical translation across neuroscience-related departments and clinical units. It links laboratory groups, hospital services, and graduate training to support basic science, neuroimaging, neurosurgery, and clinical trials. The network fosters partnerships with national and international bodies including the Medical Research Council, Wellcome Trust, National Institute for Health and Care Research, and industry partners such as GlaxoSmithKline, AstraZeneca, and Roche.

History

The initiative grew from collaborations between historic Oxford entities including the Nuffield Department of Clinical Neurosciences, the Department of Physiology, Anatomy and Genetics, the Department of Experimental Psychology, and the John Radcliffe Hospital. Key milestones involved funding from the Wellcome Trust, awards from the Medical Research Council, and strategic alignment with the Oxford University Hospitals NHS Foundation Trust. The network expanded alongside major projects such as the establishment of the Christ Church-linked laboratory clusters, participation in consortia like the Human Brain Project and contributions to multicenter trials coordinated with the European Commission and the National Institutes of Health.

Research and Departments

Research spans cognitive neuroscience, systems neuroscience, cellular neuroscience, neuropharmacology, and computational neuroscience across departments such as the Department of Psychiatry, the Department of Clinical Neurosciences, the MRC Weatherall Institute of Molecular Medicine, and the Sir William Dunn School of Pathology. Groups collaborate with centres like the Oxford Centre for Human Brain Activity, the Oxford Centre for Neuroethics, and the Nuffield Department of Surgical Sciences to investigate disorders studied in trials registered with the European Medicines Agency and outcomes reported to bodies like the National Institute for Health and Care Excellence. Research outputs intersect with projects led by investigators at institutions such as Harvard University, Massachusetts Institute of Technology, Max Planck Society, Karolinska Institutet, and University College London.

Education and Training

Training programs include undergraduate modules within Keble College and postgraduate programs run by the Department of Pharmacology and the Graduate School. Doctoral training partnerships link to doctoral training centres funded by the Biotechnology and Biological Sciences Research Council and the EPSRC and include collaborations with the Wellcome Trust Centre for Human Genetics. Clinical fellowships integrate with training pathways accredited by the General Medical Council and specialty training in partnership with the Royal College of Physicians and the Royal College of Surgeons.

Clinical and Translational Programs

Clinical translation operates through the Oxford University Hospitals NHS Foundation Trust and specialized clinics at the John Radcliffe Hospital and the Nuffield Orthopaedic Centre. Trials in stroke, epilepsy, Parkinson's disease, multiple sclerosis, and dementia have been run in collaboration with networks such as the Stroke Association and the Alzheimer's Society. Translational pipelines engage regulatory bodies including the Medicines and Healthcare products Regulatory Agency and drive early-phase studies with partners like Pfizer, Bristol-Myers Squibb, and the European Research Council.

Facilities and Institutes

Core facilities include imaging platforms with scanners used in projects linked to the Human Connectome Project and facilities at the Oxford Centre for Human Brain Activity and the Oxford Biomedical Research Centre. Wet-lab capacity is provided by units at the MRC Mitochondrial Biology Unit, the Henry Wellcome Building for Genomic Medicine, and shared resources coordinated with the Oxford Martin School. Specialized infrastructure supports neurophysiology, optogenetics, single-cell sequencing, and high-performance computing through partnerships with the Rutherford Appleton Laboratory.

Collaborations and Partnerships

International collaborations extend to consortia and universities such as Stanford University, Columbia University, Imperial College London, ETH Zurich, and research organisations including the Allen Institute for Brain Science and the Francis Crick Institute. Industry partnerships include alliances with Johnson & Johnson, Novartis, and biotechnology firms supported by the Oxford Science Enterprises. Funding and policy engagement occur with stakeholders like the UK Research and Innovation and the Bill & Melinda Gates Foundation.

Public Engagement and Outreach

Public engagement activities include contributions to festivals such as the Cheltenham Science Festival and the Brighton Science Festival, public lectures at venues like the Sheldonian Theatre, and citizen science projects with organisations such as the Wellcome Collection. Outreach works with patient charities including Parkinson's UK, Motor Neurone Disease Association, and Young Minds to co-design resources and to disseminate findings via media partners including the BBC and science publishers like Nature Publishing Group.

Category:University of Oxford